ATE432692T1 - Tabletten, die in der mundhöhle schnell zerfallen - Google Patents

Tabletten, die in der mundhöhle schnell zerfallen

Info

Publication number
ATE432692T1
ATE432692T1 AT02703917T AT02703917T ATE432692T1 AT E432692 T1 ATE432692 T1 AT E432692T1 AT 02703917 T AT02703917 T AT 02703917T AT 02703917 T AT02703917 T AT 02703917T AT E432692 T1 ATE432692 T1 AT E432692T1
Authority
AT
Austria
Prior art keywords
oral cavity
tablets
dispose
quickly
water
Prior art date
Application number
AT02703917T
Other languages
English (en)
Inventor
Motohiro Ohta
Muneko Kuboyama
Hirokazu Yoshimoto
Yasushi Watanabe
Kiyoshi Morimoto
Makoto Kosugi
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18921782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE432692(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Application granted granted Critical
Publication of ATE432692T1 publication Critical patent/ATE432692T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02703917T 2001-03-06 2002-03-05 Tabletten, die in der mundhöhle schnell zerfallen ATE432692T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001062678 2001-03-06
PCT/JP2002/002048 WO2002069933A1 (fr) 2001-03-06 2002-03-05 Comprimés à délitement rapide dans la bouche

Publications (1)

Publication Number Publication Date
ATE432692T1 true ATE432692T1 (de) 2009-06-15

Family

ID=18921782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02703917T ATE432692T1 (de) 2001-03-06 2002-03-05 Tabletten, die in der mundhöhle schnell zerfallen

Country Status (12)

Country Link
US (1) US20040122106A1 (de)
EP (1) EP1366759B1 (de)
JP (1) JP4365095B2 (de)
KR (1) KR20030094272A (de)
CN (1) CN1239151C (de)
AT (1) ATE432692T1 (de)
AU (1) AU2002237548B2 (de)
CA (1) CA2439873A1 (de)
DE (1) DE60232496D1 (de)
ES (1) ES2325484T3 (de)
RU (1) RU2003129506A (de)
WO (1) WO2002069933A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
JP5584509B2 (ja) * 2003-02-28 2014-09-03 東和薬品株式会社 口腔内崩壊錠剤
JP4551627B2 (ja) * 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
WO2005004923A1 (ja) * 2003-07-10 2005-01-20 Kyowa Hakko Kogyo Co., Ltd. 錠剤およびその製造方法
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
JP4547161B2 (ja) * 2004-01-22 2010-09-22 エスエス製薬株式会社 用時溶解型速溶性固形製剤
GB0408078D0 (en) * 2004-04-08 2004-05-12 Novartis Ag Organic compounds
JP5208348B2 (ja) * 2004-05-13 2013-06-12 旭化成ファーマ株式会社 ナフトピジルを含有する医薬
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US7820198B2 (en) * 2004-10-19 2010-10-26 Arch Chemicals, Inc. Pool chemical tablet
IL164679A0 (en) * 2004-10-19 2005-12-18 Rafi Bronstein Scitex Vision L A method of inkjet printing with image quality control
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
PT1920786E (pt) * 2005-07-25 2011-12-28 Otsuka Pharma Co Ltd Preparação oral para avaliar a capacidade metabólica da pirimidina
JP5100391B2 (ja) * 2005-10-05 2012-12-19 京都薬品工業株式会社 経口用組成物
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
PE20070698A1 (es) 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
CN101646461A (zh) 2007-03-13 2010-02-10 大日本住友制药株式会社 口腔崩解片
US20090149433A1 (en) 2007-11-13 2009-06-11 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
JP5280420B2 (ja) * 2010-10-18 2013-09-04 旭化成ファーマ株式会社 ナフトピジルを含有する医薬の製造方法
CN107028900A (zh) 2010-12-02 2017-08-11 艾戴尔医药公司 快速分散颗粒、口腔崩解片以及方法
JP6004882B2 (ja) * 2012-10-15 2016-10-12 三菱商事フードテック株式会社 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤
US20140179655A1 (en) * 2012-12-20 2014-06-26 Solural Pharma ApS Solid oral dosage form of testosterone derivative
CN104645336B (zh) * 2015-01-04 2017-08-29 深圳市药品检验研究院 一种复合辅料及其制备方法和用途
CN104824310A (zh) * 2015-04-20 2015-08-12 王永帮 一种无异味的砂型奶糖
CN104770543A (zh) * 2015-04-20 2015-07-15 王永帮 一种砂型奶糖用矫味剂
CA3085065C (en) 2017-12-08 2023-12-05 Fertin Pharma A/S Formulations providing high nicotine concentrations
WO2019110072A1 (en) 2017-12-08 2019-06-13 Fertin Pharma A/S Nicotine tablet
JP7094563B2 (ja) * 2019-08-05 2022-07-04 学校法人松山大学 錠剤及びその製造方法並びに打錠用粉末
JP2022130075A (ja) * 2021-02-25 2022-09-06 フロイント産業株式会社 顆粒及びその製造方法、並びに錠剤
EP4329759A4 (de) 2021-04-30 2025-07-16 Mind Medicine Inc Lsd-salzkristallformen
JP7846211B2 (ja) * 2021-08-19 2026-04-14 デフィニウム セラピューティクス ユーエス, インコーポレイテッド 治療適用のためのd-リゼルグ酸ジエチルアミドの即時放出製剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6185330A (ja) * 1984-10-04 1986-04-30 Fuji Kagaku Kogyo Kk 直打用賦形薬の製造法
JPH0830005B2 (ja) * 1985-09-25 1996-03-27 ゲルゲリイ、ゲルハルト 崩壊性錠剤とその製造方法
DE59006217D1 (de) * 1989-11-30 1994-07-28 Danubia Petrochem Polymere Nicht wirkstoffretardierender Pressling, Verfahren zu dessen Herstellung und Verwendung von Polyhydroxybuttersäure zur Herstellung eines solchen Presslings.
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
FR2710637B1 (fr) * 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
JP3797387B2 (ja) * 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
DE69738829D1 (de) * 1996-07-12 2008-08-21 Daiichi Seiyaku Co Schnell zerfallende, druckgeformte Materialien sowie Prozess zu deren Herstellung
JP3296412B2 (ja) * 1997-04-25 2002-07-02 田辺製薬株式会社 成型製剤及びその製法
JP4196417B2 (ja) * 1997-06-27 2008-12-17 大正製薬株式会社 口腔内速崩錠及びその製造方法
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
JPH11169437A (ja) * 1997-12-03 1999-06-29 Kyowa Hakko Kogyo Co Ltd 錠剤の製造方法
US6365182B1 (en) * 1998-08-12 2002-04-02 Cima Labs Inc. Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
WO2000020033A1 (en) * 1998-10-05 2000-04-13 Eisai Co., Ltd. Tablets immediately disintegrating in the oral cavity
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
PT1260215E (pt) * 2000-03-01 2009-09-03 Eisai R&D Man Co Ltd Comprimido de desintegração rápida que contém poli(álcool vinílico)

Also Published As

Publication number Publication date
CA2439873A1 (en) 2002-09-12
EP1366759A1 (de) 2003-12-03
KR20030094272A (ko) 2003-12-11
RU2003129506A (ru) 2005-03-10
JP4365095B2 (ja) 2009-11-18
EP1366759A4 (de) 2006-04-19
JPWO2002069933A1 (ja) 2004-07-02
US20040122106A1 (en) 2004-06-24
AU2002237548B2 (en) 2007-04-05
EP1366759B1 (de) 2009-06-03
WO2002069933A1 (fr) 2002-09-12
DE60232496D1 (de) 2009-07-16
ES2325484T3 (es) 2009-09-07
CN1239151C (zh) 2006-02-01
CN1494418A (zh) 2004-05-05

Similar Documents

Publication Publication Date Title
ATE432692T1 (de) Tabletten, die in der mundhöhle schnell zerfallen
ATE333265T1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
ATE516017T1 (de) Feste pharmazeutische dosierform enthaltende ritonavir
HRP20030951B1 (hr) Formulacije jednodnevnih doza oksikodona
CA2273420A1 (fr) Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale
HUP0402293A2 (hu) Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására
ATE445597T1 (de) ß2-OXO-1-PYRROLIDINDERIVATE UND IHRE PHARMAZEUTISCHE VERWENDUNGß
IN2014DN10834A (de)
DK1121103T3 (da) Oralt disintegrerbare tabletter, der omfatter en benzimidazol
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
ECSP055568A (es) Composición de comprimido de liberación sostenida de pramipexol
EP1246622A4 (de) Neue substituierte dosisformen von benzimidazolen und verfahren zur deren verwendung
BG108516A (en) Pharmaceutical formulation
NO20026123D0 (no) Farmasöytiske sammensetninger
ATE442158T1 (de) Oral verabreichte pharmazeutische zusammensetzungen mit einem abgabemittel in mikronisierter form
MXPA04001933A (es) Composicion farmaceutica que comprende lumiracoxib.
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
YU46503A (sh) Farmaceutski oblik dronedarona za parenteralnu upotrebu
SE0001916D0 (sv) Novel formulation
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
MA27262A1 (fr) Microcapsules pour la liberation retardee et controlee du perindopril
AR045724A1 (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico
CO5560534A2 (es) Formulaciones farmaceuticas
RU2001109481A (ru) Антиангинальное средство

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties